Does Side of Onset Influence the Pattern of Cerebral Atrophy in Parkinson’s Disease? by Maria C. A. Santos et al.
September 2016 | Volume 7 | Article 1451
Original research
published: 12 September 2016
doi: 10.3389/fneur.2016.00145
Frontiers in Neurology | www.frontiersin.org
Edited by: 
Ryuji Kaji, 
University of Tokushima, Japan
Reviewed by: 
Graziella Madeo, 
University of Rome Tor Vergata, Italy  
Renato Puppi Munhoz, 
Pontifical Catholic University of 
Paraná, Brazil
*Correspondence:
Maria C. A. Santos  
mariacristina.arci@gmail.com
Specialty section: 
This article was submitted to 
Movement Disorders, 
a section of the journal 
Frontiers in Neurology
Received: 14 February 2016
Accepted: 29 August 2016
Published: 12 September 2016
Citation: 
Santos MCA, Campos LS, 
Guimarães RP, Piccinin CC, 
Azevedo PC, Piovesana LG, 
De Campos BM, Scarparo Amato-
Filho AC, Cendes F and D’Abreu A 
(2016) Does Side of Onset Influence 
the Pattern of Cerebral Atrophy in 
Parkinson’s Disease? 
Front. Neurol. 7:145. 
doi: 10.3389/fneur.2016.00145
Does side of Onset influence the 
Pattern of cerebral atrophy in 
Parkinson’s Disease?
Maria C. A. Santos1*, Lidiane S. Campos1, Rachel P. Guimarães1, Camila C. Piccinin1, 
Paula C. Azevedo1, Luiza G. Piovesana1, Brunno Machado De Campos1,  
Augusto C. Scarparo Amato-Filho2, Fernando Cendes1 and Anelyssa D’Abreu1
1 Neuroimaging Laboratory, Department of Neurology, State University of Campinas – UNICAMP, Campinas, São Paulo, 
Brazil, 2 Department of Radiology, State University of Campinas – UNICAMP, Campinas, São Paulo, Brazil
Background: Imaging studies have revealed widespread neurodegeneration in 
Parkinson’s disease (PD), but only a few considered the issue of asymmetrical clinical 
presentations.
Objective: To investigate if the side of onset influences the pattern of gray matter (GM) 
atrophy in PD.
Methods: Sixty patients (57.87 ± 10.27 years) diagnosed with idiopathic PD according to 
the U.K. Brain Bank criteria, 26 with right-sided disease onset (RDO) and 34 with left-sided 
disease onset (LDO), were compared to 80 healthy controls (HC) (57.1 ± 9.47 years). We 
acquired T1-weighted images on a 3 T scanner. Images were processed and analyzed 
with VBM8 (SPM8/Dartel) on Matlab R2012b platform. Statistic assessments included a 
two-sample test (family-wise error p < 0.05) with extent threshold of 20 voxels.
results: Compared to HC, LDO patients had GM atrophy in the insula, putamen, ante-
rior cingulate, frontotemporal cortex, and right caudate, while the RDO group showed 
atrophy at the anterior cingulate, insula, frontotemporal, and occipital cortex.
conclusion: This study revealed widespread GM atrophy in PD, predominantly in the 
left hemisphere, regardless of the side of onset. Future investigations should also con-
sider handedness and side of onset to better characterize cerebral involvement and its 
progression in PD.
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inTrODUcTiOn
Parkinson’s disease (PD) is well known for its asymmetrical presentation of motor signs, such as 
tremor, rigidity, and bradykinesia (1). However, the association between PD side of onset, clinical 
characteristics, and brain morphological alterations are not clear.
Studies have suggested that the side of motor onset is associated with asymmetric brain 
changes in early PD, worse in the contralateral side (2, 3). Functional imaging showed a 
reduced cerebral lateralization pattern in PD (4). Patients with left-sided disease onset (LDO) 
present thinning of motor-related areas in the contralateral hemisphere (5), while patients with 
TaBle 1 | Demographic and clinical data of PD patients and hc.
groups rDO lDO Total p value hc
N 24 36 60 – 80
Age (years) 56.77 ± 11.42 58.71 ± 9.38 57.87 ± 10.27 0.474 57.1 ± 9.47
Sex (male) 19 24 43 – 31
DD (years) 6.61 ± 7.93 8.68 ± 5.50 7.78 ± 6.68 0.185
HY 2.31 ± 1.15 2.66 ± 0.85 2.51 ± 0.99 0.107
UPDRS 33.73 ± 19.67 36.82 ± 17.63 35.48 ± 18.44 0.524
SCHWAB (%) 73.46 ± 23.99 72.06 ± 19.97 72.67 ± 21.62 0.806
SCOPA 19.92 ± 5.97 19.59 ± 6.11 20.09 ± 5.43 0.836
NMSS 68.31 ± 50.35 64.18 ± 41.92 65.97 ± 45.40 0.730
N, absolute number of subjects per group; DD, disease duration; HY, Hoehn and Yahr; UPDRS, Unified Parkinson’s Disease Rating Scale; SCHWAB, Schwab and England Activities 
of Daily Living; SCOPA, Scales for Outcomes of Parkinson’s disease; NMSS, Non-motor symptom scale; RDO, right-sided disease onset; LDO, left-sided disease onset; HC, healthy 
control.
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predominantly right-sided disease onset (RDO) had a lower 
dopamine transporter uptake in the left putamen compared 
to the right putamen, suggesting that asymmetry of disease is 
not random (6).
However, there is no consensus if cerebral asymmetrical 
pathology is related to clinical symptoms or signs (7–10). No 
definitive pattern of differential brain involvement has been 
reported in asymmetric disease. Our goal was to perform an 
exploratory analysis to investigate the relationship between corti-
cal gray matter (GM) atrophy and motor asymmetry in PD.
MaTerials anD MeThODs
Participants
The Ethics Committee of the University of Campinas 
(UNICAMP) Hospital approved the study, and all participants 
signed an informed consent before any study related procedure. 
Sixty patients (57.87 ± 10.27 years) with PD, diagnosed according 
to the UK Parkinson’s Disease Society Brain Bank criteria were 
consecutively recruited at the Movement Disorders Outpatient 
Clinic, a major tertiary hospital with a catchment area of six 
million subjects. No subjects declined participation in the study. 
All underwent a complete clinical evaluation, including family 
history, review of PD history, physical and neurological examina-
tion, Unified Parkinson’s Disease Rating Scale (UPDRS), Modified 
Hoehn and Yahr (HY), Scales for Outcomes of Parkinson’s disease 
(SCOPA), Non-motor symptom scale (NMSS), and Schwab and 
England Activities of Daily Living, performed by Movement 
Disorders Specialists. No patient was present with significant lan-
guage deficit. Patients with bilateral onset or axial symptoms were 
excluded. Forty-five PD subjects declared right-hand dominance 
(88.24%), six declared left-hand dominance, and the information 
was not available for nine.
Side of onset was defined by the patient and family interview 
as the side that was first symptomatic. This information was 
confirmed in the medical charts. Most patients in our clinic 
are under follow up since diagnosis, and this information is 
highly reliable. We did not take into consideration the asym-
metry at the time of evaluation. Twenty-six patients reported 
RDO, and 34 reported LDO. Concordance between side of 
onset and self-declared hand dominance was 52.94% (Pearson 
chi-square = 2.22, p = 0.136).
The control group included 80 healthy controls (HC) 
(57.1 ± 9.47 years) with no history of neurologic or psychiatric 
disorders and a normal neurologic examination, and they came 
from the same base population (Campinas metropolitan area, 
SP-Brazil). There was no evidence of mild cognitive impair-
ment or dementia using DSM V criteria in this group. Hand 
dominance information was not available for these subjects. 
We compared the clinical characteristics between patients and 
controls using a multivariate model, controlling for age, sex, 
and disease duration, and we did not observe any significant 
statistical difference (Table 1).
For the statistical analysis, we used STATA 13.1 version. Level 
of significance was established at p < 0.05.
image acquisition and analysis
We acquired anatomical T1-weighted MRI images with isotropic 
voxels of 1 mm in the sagittal plane on a 3 T Achieva MR unit-
PHILIPS Intera® scanner, release 2.6.1.0. The imaging protocol 
included the following parameters: 1  mm thick, flip angle 8°, 
TR 7.1, TE 3.2, matrix 240 × 240, and FOV 240 mm × 240 mm. 
A neuroradiologist analyzed the images in a blinded fashion, 
to identify movement artifacts and pathological abnormalities, 
which would lead to exclusion of the subjects from the study. 
None were excluded at this point.
We converted images from Dicom to the Nifti format using 
DCM2Nii.1 We placed the center point on the anterior commis-
sure and aligned the images using the display button, available 
on SPM 8 (11).
We used VBM8 toolbox of the statistical parametric map-
ping (SPM8)2 and the Diffeomorphic Anatomical Registration 
Exponentiated Lie Algebra (Dartel) software on Matlab R2012b 
platform to process and analyze the images. VBM allows for 
a voxel-wise comparison of local GM differences between two 
groups (12). Briefly, VBM-optimized procedure (11) involves, 
first, the segmentation of the original structural MRI image 
in native space in GM, white matter (WM), and cerebrospinal 
fluid (CSF) tissues. Next, the software normalizes GM and WM 
images to templates in stereotactic space to acquire optimized 
1 http://people.cas.sc.edu/rorden/mricron/dcm2nii.html
2 http://www.fil.ion.ucl.ac.uk/spm 
TaBle 2 | areas with gM atrophy in VBM analyses of rDO vs. hc and lDO vs. hc.
Mni coordinates (X, Y, Z) p value FWe T-score z-score number of voxels localization (aal)
lDO vs. hc
57, 5, −24 0.001 5.76 5.37 228 Temporal_Mid_R (176)
Temporal_Pole_Mid_R (52)
39, 17, −21 0.000 6.69 6.11 1678 Insula_R (796)
 Temporal_Pole_Sup_R (379)
Frontal_Inf_Orb_R (229)
Frontal_Inf_Oper_R (56)
Putamen_R (33)
Frontal_Inf_Tri_R (6)
−35, 15, −18 0.001 5.82 5.42 166 Temporal_Pole_Sup_L (60)
Frontal_Inf_Orb_L (43)
Insula_L (29)
47, 56, −9 0.001 5.87 5.45 257 Frontal_Mid_Orb_R (212)
Frontal_Mid_R (29)
Frontal_Inf_Orb_R (7)
−23, 62, −9 0.003 5.54 5.19 166 Frontal_Sup_Orb_L (92)
Frontal_Mid_Orb_L (37)
Frontal_Mid_L (19)
Frontal_Sup_L (18)
−30, 14, 7 0.000 7.45 6.68 1965 Insula_L (1019)
Frontal_Inf_Oper_L (588)
Frontal_Inf_Tri_L (124)
Rolandic_Oper_L (50)
Putamen_L (12)
2, 39, 22 0.000 6.42 5.89 1002 Cingulum_Ant_L (307)
Cingulum_Ant_R (266)
Frontal_Sup_Medial_L (235)
Frontal_Sup_Medial_R (160)
Frontal_Med_Orb_R (18)
Cingulum_Mid_R (4)
Frontal_Med_Orb_L (1)
33, 60, 10 0.010 5.25 4.94 104 Frontal_Mid_R (66)
Frontal_Sup_R (25)
Frontal_Sup_Orb_R (9)
Frontal_Mid_Orb_R (4)
9, 11, 9 0.013 5.17 4.88 145 Caudate_R (145)
−20, 48, 31 0.001 5.95 5.52 467 Frontal_Sup_L (267)
Frontal_Mid_L (200)
rDO vs. hc
−35,−93, −0 0.000 4.04 3.88 42 Occipital_Mid_L (24)
56, −33, −3 0.000 4.09 3.92 39 Temporal_Mid_R (39)
−3, 59, −2 0.000 4.22 4.04 58 Frontal_Med_Orb_L (38)
Frontal_Sup_Medial_L (20)
−33, 12, 7 0.000 4.49 4.27 199 Insula_L (180)
Frontal_Inf_Oper_L (13)
42, −6, 10 0.000 4.37 4.17 103 Rolandic_Oper_R (71)
Insula_R (32)
0, 53, 15 0.000 4.74 4.49 204 Frontal_Sup_Medial_L (173)
Cingulum_Ant_L (21)
Cingulum_Ant_R (6)
Frontal_Sup_Medial_R (2)
17, −96, 28 0.000 4.16 3.98 27 Occipital_Sup_R (21)
Total of voxels corresponds to the number of voxels of each cluster (p < 0.05 FWE).
Height threshold: T = 4.80 and T = 3.86, respectively; Extent threshold: K = 20 voxels; voxel size: 1 mm3.
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FigUre 1 | areas with gM atrophy labeled in yellow in VBM analysis of lDO PD patients vs. hc.
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normalization parameters, which are applied to the raw images. 
Then, we performed an automatic segmentation of the normal-
ized images. GM images were smoothed using an 8-mm full 
width at half maximum (FWHM) isotropic Gaussian kernel. 
Finally, we performed a statistical analysis, employing the 
general linear model (GLM). We obtained the results on sta-
tistical parametric map showing regions of GM concentration 
with significant differences between the experimental groups 
(13). Correction for multiple comparisons used the Theory of 
Random Fields (12).
FigUre 2 | areas with gM atrophy labeled in yellow in VBM analysis of rDO PD patients vs. hc.
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We displayed the results using SPM12 on Matlab R2014b and 
xjView (Human Neuroimaging Lab, Baylor College of Medicine, 
Houston, TX, USA). We accessed group comparisons by SPM 
through the family-wise error (FWE) at a threshold of p < 0.05, 
corrected for multiple comparisons, with an extent threshold of 
K = 20 voxels. The brain areas were localized according to the 
automated anatomical labeling available on The Online Brain 
Atlas Reconciliation Tool (OBART) (14).
Primary analysis included RDO vs. HC and LDO vs. HC. 
A homogeneity test using covariance excluded one RDO patient.
6Santos et al. Laterality Effects on Parkinson’s Disease Atrophy
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resUlTs
There were no statistical significant differences between RDO and 
LDO groups in HY, NMSS, and Schwab and England scale scores 
(Table 1).
lDO vs. hc
Brain atrophy was slightly predominant in the left hemisphere, 
involving the medial superior temporal pole, frontal lobe, insula, 
rolandic operculum, putamen, and anterior cingulate. In the 
right hemisphere, we observed GM atrophy in the medial and 
superior temporal poles, insula, frontal lobe, putamen, anterior 
and medium cingulate, and caudate (p < 0.05, FWE corrected) 
(Table 2, Figure 1).
rDO vs. hc
Compared with HC, we identified GM atrophy in PD mainly in 
left hemisphere, including the insula, frontal lobe, and anterior 
cingulate. In right hemisphere, GM reduction was localized in the 
temporal medial gyrus, the rolandic operculum, insula, anterior 
cingulate, and occipital superior gyrus (p < 0.05, FWE corrected) 
(Table 2, Figure 2).
DiscUssiOn
This exploratory study aimed to define GM changes in PD 
patients, taking into account the asymmetrical onset of the motor 
signs. Comparing both the LDO to HC and the RDO to HC, the 
atrophic areas were predominantly localized in the left hemi-
sphere. We observed fewer clusters of GM atrophy in the RDO 
group than in the LDO group (Table 2, Figure 1). In the LDO 
group, we identified atrophy in 5773 voxels, 2672 voxels in the 
right hemisphere (46.28%) and 3101 voxels in the left (53.72%), 
while in the RDO group, we found atrophy in only 640 voxels, 
469 in the left hemisphere (73.28%) and 171 voxels in the right 
hemisphere (26.72%). We did not observe significant differences 
between both groups regarding age, disease duration, and disease 
severity, as measured by clinical scales. The two central findings 
of this study are (1) brain changes are asymmetric, but not neces-
sarily worse contralateral to the side of onset of the disease and 
(2) there is greater structural brain atrophy in patients with LDO 
than RDO.
The motor signs and symptoms of PD are initially unilateral 
in most cases, corresponding to stage 1 of HY scale. Therefore, an 
asymmetric pattern of brain damage is an intuitive expectation 
although motor severity may be more related to basal ganglia 
rather than cortical changes (2). As disease duration increases, 
PD tends to become more symmetrical (15).
Our findings corroborate clinical studies suggesting clinical 
differences between LDO and RDO. The side of disease onset 
and handedness appear to influence disease progression and 
its features, including non-motor symptoms (16, 17). LDO 
may be associated with more significant cognitive decline 
and reduced goal-directed behavior (18). Left-handed LDO is 
related to longer disease duration (19), whereas patients with 
RDO usually have difficulties with language-related tasks and 
verbal memory. LDO patients with predominant rigidity–brad-
ykinesia have a worse prognosis than RDO with predominant 
tremor (20–22). Moreover, the left hemisphere appears to have 
a stronger association with the ipsilateral side of the body than 
the right one (23).
Our findings also strengthen the hypothesis of asymmetrical 
neurodegeneration in PD. Asymmetries in the substantia nigra 
(SN) and the putamen in early PD have been linked to unilateral 
motor symptoms (2). One analysis showed reduction of dopa-
mine transporter availability in bilateral putamen; however, the 
decrease was greater in the left putamen in right-handed RDO 
(6). RDO with mild cognitive impairment had a reduction of 
the left thalamus volume compared to LDO, which suggests that 
dominance of motor manifestations might be associated with a 
pattern of lateralized brain loss (24). LDO patients have worse 
visual–spatial performance compared to RDO, and GM decrease 
was observed mainly in the hemisphere contralateral to the side 
of disease onset, primarily in the right middle frontal gyrus and 
the precuneus (10). Subjects with right-handed RDO have less 
cortical thinning than right-handed LDO, suggesting a possible 
neuroprotective effect of handedness on the contralateral motor 
cortex (5).
The major limitation of our study was the lack of adjustment 
for handiness in the analysis. This information was lacking for 
some subjects, and had we performed the analysis using four 
subgroups, the results would probably be meaningless due to the 
small size of each sample. Due to the exploratory nature of this 
study and since most imaging studies in PD do not take handed-
ness into consideration (9, 24, 25), we still believe our results are 
worth reporting. However, we should point that most studies had 
a predominant right-handed population, and the asymmetric 
cerebral alterations observed might be due to handedness, and 
not necessarily side of disease onset. Other neurodegenerative 
diseases, such as Alzheimer’s disease, are not commonly inves-
tigated for laterality, and most studies focus on patterns of 
disease progression, showing that early atrophy occurs on medial 
temporal areas and advances toward frontal and parietal lobes 
(26). Our next step is to extend this investigation using a larger 
sample taking into account dominance and side of disease onset. 
There should also be a more detailed study of cognitive functions, 
especially language. Further research is needed to clarify the dif-
ferential patterns and importance of brain involvement in RDO 
and LDO in PD.
cOnclUsiOn
Brain atrophy in subjects with PD is bilateral, and regardless of 
the side of disease onset, atrophy seems more severe in the left 
hemisphere. It remains unclear if this left-sided predominance 
is secondary to hand dominance or if it results from a specific 
characteristic of disease progression.
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